• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GERN:US

3.6800 USD 0.0400 1.08%

As of 17:10:00 ET on 11/28/2014.

Snapshot for Geron Corp (GERN)

Open: 3.6900 Day's Range: 3.6500 - 3.7800 Volume: 2,350,412
Previous Close: 3.7200 52wk Range: 1.3134 - 6.5383 1-Yr Rtn: -27.47%

Stock Chart for GERN

No chart data available.
  • GERN:US 3.6800
  • 1D
  • 1M
  • 1Y
3.7200
Interactive GERN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GERN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2516
Est. EPS (USD) (12/2014) -0.0050
Est. PEG Ratio -
Market Cap (M USD) 578.54
Shares Outstanding (M) 157.21
30 Day Average Volume 6,549,013
Price/Book (mrq) 4.2174
Price/Sale (ttm) 446.4318
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GERN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GERN

Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

John A ScarlettPresident/CEOOlivia K BloomExec VP:Finance/CFO/Treasurer
Stephen N RosenfieldExec VP/General Counsel/SecyAndrew J Grethlein "Andy"Exec VP:Tech Operations
More Company Profile & Key Executives for GERN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil